In: Cancer treatment reviews, 2020, vol. 90, p. 11
The DNA damage response (DDR) is a well-coordinated cellular network activated by DNA damage. The unravelling of the key players in DDR, their specific inactivation in different tumor types and the synthesis of specific chemical inhibitors of DDR represent a new hot topic in cancer therapy. In this article, we will review the importance of DDR in lymphoma development and how this can be...
|
In: Archives of Gynecology and Obstetrics, 2015, vol. 291, no. 6, p. 1387-1394
|
In: Virchows Archiv, 2015, vol. 466, no. 6, p. 637-643
|
In: Cancer Causes & Control, 2015, vol. 26, no. 6, p. 881-891
|
In: World Journal of Surgery, 2015, vol. 39, no. 7, p. 1767-1772
|
In: European Journal of Nutrition, 2015, vol. 54, no. 1, p. 139-148
|
In: International Journal of Epidemiology, 2018, vol. 47, no. 1, p. 36-46
|
In: Breast Cancer Research and Treatment, 2015, vol. 149, no. 2, p. 449-460
|
In: Hormone Molecular Biology and Clinical Investigation, 2017, vol. 32, no. 1, p. -
|
In: Cancers, 2020, vol. 12, no. 10, p. 23 p
Triple-negative breast cancer (TNBC) is a heterogeneous disease that lacks effective therapeutic options. In this study, we profile eighteen TNBC cell lines for their sensitivity to the anti-proliferative action of all-trans retinoic acid (ATRA). The only three cell lines (HCC-1599, MB- 157 and MDA-MB-157) endowed with ATRA-sensitivity are characterized by genetic aberrations of the NOTCH1-gene,...
|